Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/8212
Title: Tirofiban-induced acute profound thrombocytopenia after primary angioplasty
Authors: Dursunoğlu, Dursun
Taşköylü, Ö.
Gür, S.
Sari, Hakan İsmail
Keywords: Angioplasty
Balloon
Coronary
Drug hypersensitivity
Platelet aggregation inhibitors
Thrombocytopenia
Tirofiban [supplementary concept]
acetylsalicylic acid
cilazapril
clopidogrel
heparin
isosorbide mononitrate
metoprolol
tirofiban
adult
angiocardiography
article
atrioventricular block
blood smear
case report
coronary artery obstruction
drug withdrawal
erythrocyte transfusion
human
inferior myocardial infarction
insulin treatment
male
percutaneous coronary intervention
thrombocytopenia
vascular stent
Angioplasty, Balloon, Coronary
Biological Markers
Erythrocyte Transfusion
Fibrinolytic Agents
Humans
Inferior Wall Myocardial Infarction
Male
Middle Aged
Platelet Aggregation Inhibitors
Platelet Count
Platelet Transfusion
Severity of Illness Index
Treatment Outcome
Tyrosine
Abstract: Glycoprotein IIb/IIIa inhibitors are used in the acute coronary syndromes and percutaneous coronary intervention as antiplatelet agents. However, these agents induce thrombocytopenia in approximately 1% to 5% of patients, and may lead to bleeding complications. Abciximab is associated with higher incidence of thrombocytopenia than eptifibatide and tirofiban. We describe a case of acute profound thrombocytopenia due to on tirofiban treatment in a patient who underwent primary angioplasty. © The Author(s) 2012.
URI: https://hdl.handle.net/11499/8212
https://doi.org/10.1177/0218492312445142
ISSN: 0218-4923
Appears in Collections:PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Tıp Fakültesi Koleksiyonu

Show full item record



CORE Recommender

SCOPUSTM   
Citations

10
checked on Dec 14, 2024

Page view(s)

44
checked on Aug 24, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.